Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Talzenna
Pharma
Pfizer targets broad Talzenna label in prostate cancer
Pfizer hopes an overall survival showing could expand Talzenna's reach in mCRPC beyond those with HRR mutations.
Angus Liu
Oct 10, 2024 10:18am
NICE reverses its call on Talzenna after Pfizer discount
Jan 19, 2024 7:47am
Pfizer's Talzenna wins broader prostate cancer nod than AZ rival
Jun 21, 2023 10:45am
'Eligibility challenges' derail GSK's Zejula breast cancer trial
Apr 26, 2023 1:57pm
J&J's PARP combo Akeega gets limited EU backing
Feb 24, 2023 1:27pm
Pfizer touts Talzenna in PARP prostate cancer showdown
Feb 16, 2023 10:01am
